Capillary permeability increases after inflammation with consequent leak of fluid, electrolytes, and proteins. The albumin molecule size being smaller (69 kDa) than the globulin molecule (90 -156 kDa) will leak relatively at an early stage of the disease (with moderate increase in capillary pore size) than globulin leading to albumin/globulin reversal. In cases with severe permeability changes with rapid progression to larger pore size with simultaneous leak of both albumin and globulin, albumin/globulin reversal will not occur. In this study estimation the serum protein and albumin/ globulin (A/G) ratio at frequent intervals was done to grade the severity of the condition of burn patients by assessing the severity of capillary leak.
C ontinuous capillaries are the most abundant and wide spread type of capillaries and are found in muscle, skin, lung, connective tissue, and nervous system. The intercellular (endothelium) clefts in the wall of most capillaries have a width of approximately 60 Å. Hence, in normal capillaries albumin and other plasma proteins that have larger diameter have a difficult time penetrating the cleft. Also, the efflux of the albumin, which is negatively charged, is profoundly influenced by negative charge associated with mucopolysaccharides found on the endothelial cell surface and in interendothelial clefts. In normal capillary with unaltered pore size, the transfer of protein molecule occurs through transcellular (transendothelial) route by the micropinocytic vesicle (endocytosis, vesicular transport through cytoplasm, exocytosis). Under normal capillary conditions, the mechanism like convection or bulk flow associated with high capillary fluid filtration rate may contribute significantly to the movement of plasma protein from blood to interstitium across membrane of another type of capillaries known as fenestrated capillaries that are found in the intestine. 1 Following systemic inflammatory response syndrome (SIRS) and sepsis, capillary permeability is altered due to contraction of endothelial cells (a process that involves rearrangement of cytoskeletal elements of endothelium such as F-actin and myosin). The cleft between 2 endothelial cells opens with a consequent increase in capillary permeability. These capillary changes are primarily mediated through the inflammatory mediators like cytokines, leukotrienes, prostaglandins, histamine, and oxygen free radicals. 2, 3 Depending upon the clinical severity of the injury and inflammation, there will be corresponding variations in the capillary permeability and hence mortality.
Essentially all the albumin and fibrinogen of the plasma proteins, as well as 50% to 80% of the globulins, are formed in the liver. The remainders of globulins are formed in the lymphoid tissue (plasma cells). 4 During increased proteolysis, albumin synthesis in the liver is increased in an attempt to maintain serum level. 4 Mechanism of albumin to globulin (A/G) ratio reversal due to reduced production of albumin (liver), increased production of globulin (plasma cell: multiple myeloma), or increased loss in chronic renal diseases has been well described. 4 Reversal A/G ratio in acute conditions like SIRS, burns, and sepsis is yet to be understood.
As the albumin (69 kDa) molecule is smaller than globulin (90 -156 kDa), 5, 6 it is evident that because of changes in capillary permeability, albumin will be lost from the circulation earlier and faster than globulin (Figs. 1, 2). In this study, an attempt has been made to indirectly calibrate the capillary pore size (by assigning groups 1-3) to determine the severity of changes in capillary permeability by measuring serum protein, albumin, and globulin levels.
The size of the protein molecule is fixed and remains same for all ages, either sex irrespective of etiology of the disease producing capillary permeability changes; therefore, it is considered in this study that there will be no effect of age, sex, or etiology on the grouping of patients based on the capillary pore size decided indirectly by serum protein study.
MATERIALS AND METHODS
This prospective study was conducted at the Burns Unit of Kasturba Hospital, Manipal, between March 2002 and December 2004, a total of 61 patients admitted with large wounds (Ն10% body surface area involvement) were included in this study. All the patients with preexisting comorbid conditions (diabetes, hypertension) and illnesses that may alter the baseline serum protein levels (eg, liver and kidney diseases) were excluded from the study.
All admitted patients had baseline estimations of CBP, RFT, serum electrolytes, serum total protein, S Albumin, S globulin done along with other requisite investigations like ECG, ABG, and relevant x-rays.
Serial estimation of serum protein, albumin, and globulin, and A/G ratio was done on days 1, 3, 7, and twice weekly thereafter. The entire patient received same standard burns unit treatment protocol.
Each time the protein estimations were done, and the patients were allotted into 1 of 3 groups based on the total protein level; group 1 (total protein: 6 -8 g/dL): (10/61 patients, none of the patient in group 1 had A/G ratio Ͻ0.6), group 2 (total protein: 5.1-5.9 g/dL): (11/61 patients, 1 patient in group 2 had A/G ratio Ͻ0.6), group 3 (total protein: Յ5.0 g/dL): (20/61 patients, 4 patient in group 3 had A/G ratio Ͻ0.6). All those patients who shifted from one group to other during the study were classified as group shifters. The patients in a given group were shifted to other groups depending on changes in their protein levels.
1. Only once shifted from one group to other (13/20 patients). 2. More than once shifted from one group to other (7/20 patients).
(Reference levels: Total protein 6.0 -8.0 g/dL, serum albumin 3.5-5 g/dL, and of serum globulin 1.8 -3.4 g/dL).
Data were analyzed by Kaplan and Meier survival analysis method. Median survival times in various groups were compared by log-rank test. In group shifters, the mean time (days) required for shifting from one group to other just before discharge in survivors and just before death in expired cases was calculated and compared using independent t test. In all analysis P Ͻ 0.05 was considered as significant.
RESULTS
All 61 patients in the study were between the ages of 1 and 75 years with median age of 32 years (interquartile range ͓IQR͔ ϭ 19.5-38 years) and the male to female ratio was 35:26. Forty-one patients (67.21%) remained in the same group from admission to discharge or death and classified in 3 groups (group 1, 2, and 3). Remaining 20 patients, due to changes in serum protein, were shifted from one group to other appropriate group and classified as group shifters.
Group 1 (10 Patients)
There were 10 patients (male/female ratio: 8/2, age range: 3-54 years with median: 40.5 years ͓IQR ϭ 17.5-49.5 years͔, total body surface area burn ranging from 15% to 33% with median: 25% ͓IQR ϭ 16.5%-32.5%͔). All of them were having A/G ratio Ͼ0.6 g/dL. All survived with median hospital stay of 18 days (range: 15-35 days and IQR ϭ 15-20.5 days).
Group 2 (11 Patients)
There were 11 patients (male/female ratio: 6/5, age range: 1-62 years with median: 35 years ͓IQR ϭ 2-42 years͔, total BSA burn ranging form 13% to 30% with median: 20% ͓IQR ϭ 13%-25%͔). Ten (90.9%) patients were having A/G ratio Ͼ0.6 g/dL and 1 had Ͻ0.6 g/dL. All survived with median hospital stay of 19 days (range: 11-55 days ͓IQR ϭ 15-23 days͔).
Group 3 (20 Patients)
There were 20 patients (male/female ratio: 11/9, age range: 1-60 years with median: 24.5 years ͓IQR ϭ 16 -35͔, total BSA burn ranging from 20% to 100% with median: 66% ͓IQR ϭ 32%-95%͔). Sixteen patients (80%) were having A/G ratio Ͼ0.6 and 4 (4/20) patients Ͻ0.6. All except one (95%) expired with median hospital stay of 3 days (range: 1-26 days, IQR ϭ 1-5days). One survivor had hospital stay of 22 days.
Group Shifters (20 Patients)
There were 20 patients (male/female ratio: 14/6, age range: 2-75 years with median: 33.5 years ͓IQR ϭ 26 -42͔, total BSA burn ranging from 15% to 95% with median: 35.5% ͓IQR ϭ 24%-51%͔) who showed changes in their protein value during its course of treatment, shifted from one group to other and were classified as group shifters. All the group shifters had A/G ratio Ͼ0.6 at the time of inclusion into the study.
It was also noticed that clinical features of an improvement or deterioration was followed by the shift in group, thus giving indication of changes in clinical status of the patient before any visible clinical signs and symptoms. They were classified depending on the number of group shifted during the study.
Only Once Shifted From One Group to Other (13 Patients)
Thirteen (65%) patients (male/female ratio: 9/4, age range: 2-75 years with median: 34 years ͓IQR ϭ 25-45͔, total BSA burn ranging from 15% to 95% with median: 42% ͓IQR ϭ 27.5%-56.5%͔) were shifted from one group to other only once and classified as single group shifters. Seven (7/13; 53.85%) single group shifters survived with median hospital stay of 42days (range: 17-51days). Four (4/7) of the survivors had A/G ratio Ͻ0.6 at the time of discharge. Remaining 6 (6/13; 46.15%) patients expired with median hospital stay of 6.5 days (range: 4 -11days). Three (3/6) of the expired cases had A/G ratio Ͻ0.6 at the time of death.
More Than Once Shifted From One Group to Other (Multiple Group shifters, 7 Patients)
Seven (35%) patients (male/female ratio: 5/2, age range: 25-42 years with median: 33 years, total BSA burn 20%-51% with median: 26%) were shifted more than once to other groups and were classified as multiple group shifters. Six (6/7) multiple group shifters survived with average hospital stay of 49.5 days (median: 41.5 days) and only expired case (1/7; 14.3%) had hospital stay for 24 days before death. All the multiple group shifter survivors showed A/G ratio Ͼ0.6 at the time of discharge and expired case had A/G ratio Ͻ0.6 at the time of death.
Mortality
Of 61 patients under study, 26 patients (26/61) expired (group 1 mortality, 0/10 patients; group 2 mortality, 0/11 patients; group 3 mortality, 19/20 patients; and group shifters mortality, 7/20 patients). (Table 1 ). At the time of death, 25 cases (25/26) were in group 3 (19 group 3 cases ϩ 6 from group shifters shifted to group 3 at the time of death) and 1 case (1/26) was in group 2 (One group shifter shifted to group 2 at the time of death). Of 26 expired cases, 22 had A/G ratio Ͼ0.6, and 4 had A/G ratio Ͻ0.6 at the time of inclusion into the study.
In group shifters (20 cases) the mean time (days) required for shifting from one group to other just before death or discharge; in expired (7/20) group shifter (3.4286 days Ϯ SE 0.5714) was significantly less (P Ͻ 0.003) than that in 13 survivors (8.8462 days Ϯ SE 1.4538).
DISCUSSION
Despite major advancements in our knowledge of the pathophysiology and pathogenesis of wound, infection, and inflammatory process, the ideal methods of assessing the severity of the inflammatory response are yet to be developed. Basic changes in these injuries are capillary dilatation and increase in capillary pore size leading to diapedesis and effective supply of efficient protective humoral substances, chemicals, and efficient clearing of debris from the site of injury. Locally it manifests as redness (vasodilatation), raised temperature, and local edema. If the substances (prostaglandin, C-reactive protein, and pro-inflammatory cytokines: TNF-␣, IL-1, IL-6) produced locally enters in systemic circulation in large quantity, it may lead to systemic inflammatory signs in form of fever, generalized edema, hypotension, hypoperfusion, and related complications (single organ dysfunction or failure, multiple organ dysfunction syndrome, multiple organ failure, and death). 3,6 -9 This is possible by various intracellular signaling pathways activated by different cytokines and their membrane bound receptor interactions. Cytokine-inducible transcription factors interact with their response elements in the promoter region of acute phase genes causing induction of transcription leading to a systemic acute phase response and systemic inflammation. 10 Jeschke et al 11 in their study have shown that during the intensive care unit course, 214 g of albumin (3.4 g/d) was required for substitution to maintain serum albumin levels at 2.5 mg/dL in burn patients. They 11 have considered this requirement for albumin substitution as a marker for the hepatic impairment. But the author of the present article feels that increased capillary permeability (increased pore size) may significantly contribute to the decreased albumin level in critically ill burn patients rather than impaired liver function. Furthermore, Jeschke et al 12 have demonstrated hyperplasia of the liver after burn injury; in their study, liver size and weight significantly increased during the first week after burn (mean Ϯ SEM, 85% Ϯ 5%), peaked at 2 weeks after burn (mean Ϯ SEM, 126% Ϯ 19%), and at discharge, increased by 89% Ϯ 10%. At 6, 9, and 12 months, the liver weight increased by 40% to 50% compared with the predicted liver weight. The author of the present article feels that it could be due to overactive liver (attempt to compensate for reduced protein level) rather than with impaired function. If low serum protein level is mainly because of increased capillary permeability, the liver will show compensatory over activity and hyperplasia. But if low albumin is due to impaired liver activity as suggested by Jeschke et al, 11 liver hyperplasia is less likely to occur.
Because the size of the albumin and globulin is different, the leak of one or both of these protein molecules through capillary pores leads to decrease in their plasma levels. Hence, measurement of changes in their circulating level may help in grading the capillary pore size. 6 Thus, protein levels (depending on the capillary pore size) in group 1, 2, and 3 may help in assessing the severity of inflammation and grouping the patients based on that. Depending on the progression of the pathology or effect of treatment some patients showed shift from one group to other (group shifters).
Nisten et al have demonstrated that IL-6 (proinflammatory cytokine) released in these patients stimulates protein synthesis: acute phase proteins (C-reactive proteins, fibrinogen, ␣ 1 antitrypsin) in hepatocytes and immunoglobulin synthesis in B-lymphocytes. 13 Depending on the extent of injury, IL-6 induced protein synthesis may not compensate for the proteolysis that occurs during hypermetabolic state. Low-dose bradykinin, 14 the supplementation of total parenteral nutrition with glutamine containing dipeptides, 15 and administration of human growth hormone 16 have the protein sparing effect. Infusion of glucose has also been shown to reduce nitrogen loss. 17, 18 Plasma and blood transfusion in the clinical setting to treat the patient and altered protein metabolism may have effect on the serum protein level. Hence, during the course of treatment certain amount of changes in the protein level is expected, but if the capillary permeability remains altered, there will be leak of circu-lating protein as per the size of pore, and it will not significantly affect the grouping based on the serum protein level; and depending on the changes in the protein level some of these cases will classified as group shifters. To avoid significant influence of any such changes in A/G ratio, only if A/G ratio was less than one-third of the normal value, that is 0.6 g/dL, it was considered as reversed. Normal A/G ratio was 1.5 to 1.2:1; to reduce effect of destruction of albumin (increased protein catabolism) on A/G ratio, a ratio value of Յ0.6:1 was taken as significant reversal.
Although of the proteins which decrease after burns and other trauma, albumin has been extensively studied, 16 -23 this study uses the simple and routinely measured parameters of serum protein levels and A/G ratio to grade the severity of the burn injury.
Larger the size of the capillary pore, lower will be the serum protein level (group 1-3).
If capillary pore slowly increases in size, at intermediate pore size that permits albumin loss only, A/G ratio reversal will occur. If the pore size further increases to larger size allowing loss of both albumin and globulin, the changed A/G ratio will persist (Fig. 1) . In other cases, if capillary pore rapidly change to reach a larger size allowing loss of albumin and globulin, A/G reversal may not occur (Fig. 2) . Hence, along with reduced serum protein level, A/G reversal in acute burns (slow progression of disease) appears to indicate relatively better prognosis as compared with unchanged normal A/G ratio. In our study, at the time of initial assigning group, in 22 expired cases (22/26) A/G ratio was not reversed (Ͼ0.6) and in 4 cases (8/26) the A/G ratio was reversed.
Protein loss due to capillary pore changes may be compared with leak from glomeruli where filtrate is urine and has been extensively studied. 3 In minimal change disease of the glomeruli; when foot processes of podocytes (forming slit diaphragm that controls loss of larger protein molecules in urine) develop adhesions, the damaged glomerular basement membrane traps most large proteins (Ͼ100 kDa) and result in selective proteinuria (mostly albumin) and may lead to A/G reversal. Other diseases of glomeruli producing disruption of both basement membrane and diaphragm may lead to larger pores with significant loss of both albumin and globulin. 3 Hepatic rate of albumin synthesis is increased in diseases of glomeruli, although not to levels to prevent hypoalbuminemia. 3 These permeability changes in glomerular capillaries causing proteinuria may be compared with increased permeability of capillaries of muscles, connective tissues, brain, and lungs permitting albumin loss in burns (SIRS) and sepsis.
The association between albumin level and mortality has been a matter of discussion. The study of Fritz et al in 454 consecutive cases of cardiopulmonary bypass found that by logistic regression postoperative albumin level was the strongest predictor of mortality (odd ratio: 0.86, 96% CI: 0.84 -0.89). Cutoff value of predicting 28-day mortality for postoperative albumin was 17.8 g/L. 24 Comparison of mortality figure between various groups (Tables 1, 2) showed significant difference in Kaplan survival time of group 3 as compared with that of group 1 (P Ͻ 0.0026), group 2 (P Ͻ 0.0006), and group shifters (P Ͻ 0.0000). This was in accordance with the understanding that severe capillary permeability changes (group 3) will indicate more severe pathology, will be associated with the lower serum protein values and high mortality. In group shifters the mean time (days) required for shifting from one group to other just before death or discharge in expired cases (3.4286 days Ϯ SE 0.5714) was significantly less (P Ͻ 0.003) than that in survivors (8.8462 days Ϯ SE 1.4538). This indicated speed of pore size change in response to injury and treatment and hence, prognosis.
The overall mortality figure in group 3 was 95% with mean Kaplan survival 5.3 days, as compared with 30.2% mortality in group 4 with mean Kaplan survival time of 31.8 days. The mortality results were comparable to a similar study done by the author 5 in 2002 (with 32 patients). These findings indicate that severe changes in capillary permeability in group 3 patients were associated with higher mortality. Also, associated with lower mortality with more duration of survival in group shifters probably indicates that if we act in the direction of altering capillary pore (as adjuvant treatment) in group 3 patients and succeed to convert group 3 into group shifters, we may reduce the mortality. 
